PT784481E - Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano - Google Patents
Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humanoInfo
- Publication number
- PT784481E PT784481E PT96917308T PT96917308T PT784481E PT 784481 E PT784481 E PT 784481E PT 96917308 T PT96917308 T PT 96917308T PT 96917308 T PT96917308 T PT 96917308T PT 784481 E PT784481 E PT 784481E
- Authority
- PT
- Portugal
- Prior art keywords
- fibronectin
- human plasma
- wound healing
- plasma containing
- containing wound
- Prior art date
Links
- 102000016359 Fibronectins Human genes 0.000 title abstract 4
- 108010067306 Fibronectins Proteins 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000029663 wound healing Effects 0.000 title abstract 2
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000006071 cream Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 229940100611 topical cream Drugs 0.000 abstract 1
- 229940042129 topical gel Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/488,253 US5641483A (en) | 1995-06-07 | 1995-06-07 | Wound healing formulations containing human plasma fibronectin |
Publications (1)
Publication Number | Publication Date |
---|---|
PT784481E true PT784481E (pt) | 2005-07-29 |
Family
ID=23938969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96917308T PT784481E (pt) | 1995-06-07 | 1996-06-06 | Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano |
Country Status (8)
Country | Link |
---|---|
US (1) | US5641483A (pt) |
EP (2) | EP1563844A3 (pt) |
AT (1) | ATE290397T1 (pt) |
CA (1) | CA2197244A1 (pt) |
DE (1) | DE69634430T2 (pt) |
ES (1) | ES2236733T3 (pt) |
PT (1) | PT784481E (pt) |
WO (1) | WO1996040221A1 (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583114A (en) | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
US20030105007A1 (en) * | 1995-06-07 | 2003-06-05 | Andre Beaulieu | PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds |
US6528483B2 (en) * | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
US7112320B1 (en) * | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
US5821220A (en) * | 1995-06-07 | 1998-10-13 | Andre Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
US6194378B1 (en) | 1998-02-18 | 2001-02-27 | The Research Foundation Of State University Of New York | Fibronectin peptides-based extracellular matrix for wound healing |
US6497893B1 (en) | 1999-06-30 | 2002-12-24 | Kimberly-Clark Worldwide, Inc. | Silk protein treatment composition and treated substrate for transfer to skin |
CO5150202A1 (es) | 1998-12-31 | 2002-04-29 | Kimberly Clark Co | Composicion de tisu facial y metodo para usarla para el secuestro de irritantes de la piel de la secrecion nasal |
US7261881B1 (en) | 1999-05-20 | 2007-08-28 | Yale University | Modulation of angiogenesis and wound healing |
US6500443B1 (en) | 1999-06-30 | 2002-12-31 | Kimberly-Clark Worldwide, Inc. | Delivery of a sacrificial substrate to inhibit protease permeation into skin |
US6506394B1 (en) | 1999-06-30 | 2003-01-14 | Kimberly-Clark Worldwide, Inc. | Delivery of a botanical extract to a treated substrate for transfer to skin |
MXPA02001576A (es) * | 1999-08-20 | 2004-08-12 | Andre Beaulieu | Formulaciones solidas con un contenido de fibronectina para la cicatrizacion de heridas. |
KR100469661B1 (ko) * | 2000-03-28 | 2005-02-02 | 한스바이오메드 주식회사 | 이식용 무세포 진피층 및 이의 제조방법 |
US6503524B1 (en) | 2000-06-16 | 2003-01-07 | Kimberly-Clark Worldwide, Inc. | Delivery of a skin health benefit agent to a treated substrate for transfer to skin |
US7829072B2 (en) * | 2000-07-14 | 2010-11-09 | Carter Daniel C | Serum albumin compositions for use in cleansing or dermatological products for skin or hair |
GB0119476D0 (en) * | 2001-08-09 | 2001-10-03 | Novartis Forschungsstiftlung Z | Anti-tumour agents and method of identifying anti-tumour agents |
AU2003230321B8 (en) * | 2002-05-09 | 2009-07-30 | Medigenes | A pharmaceutical composition for treatment of wounds containing blood plasma or serum |
JP2004075661A (ja) * | 2002-06-18 | 2004-03-11 | Shiseido Co Ltd | 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法 |
US7634668B2 (en) | 2002-08-22 | 2009-12-15 | Nvidia Corporation | Method and apparatus for adaptive power consumption |
AU2003901515A0 (en) * | 2003-04-02 | 2003-04-17 | Norika Holdings | Sterilisation process for pharmaceutical product |
WO2006029046A2 (en) * | 2004-09-03 | 2006-03-16 | Yale University | Use of leptin in wound healing |
US7858126B2 (en) * | 2006-08-31 | 2010-12-28 | Trinity Laboratories Inc. | Derivatives of sandalwood oil and santalols for treating cold sores and herpes |
US8700925B2 (en) | 2009-09-01 | 2014-04-15 | Nvidia Corporation | Regulating power using a fuzzy logic control system |
RU2463063C1 (ru) * | 2011-07-06 | 2012-10-10 | Федеральное государственное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации | Способ получения средства для стимуляции репаративной регенерации кожного покрова |
US20130017227A1 (en) * | 2011-07-15 | 2013-01-17 | Lambert Jr Cary Jake | Wound healing compositions and associated methods |
WO2015075406A1 (en) | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
ES2887588T3 (es) | 2015-08-13 | 2021-12-23 | Kamada Ltd | Composiciones derivadas de pasta de fracción de Cohn y uso de las mismas |
TWI674903B (zh) * | 2016-09-26 | 2019-10-21 | 國立陽明大學 | 製備改良豬血漿纖連蛋白以增強傷口癒合之應用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4455300A (en) * | 1980-03-05 | 1984-06-19 | Cutter Laboratories, Inc. | Fibronectin compositions |
US4925924A (en) * | 1984-03-27 | 1990-05-15 | University Of Medicine And Dentistry Of New Jersey | Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof |
JPS61103836A (ja) * | 1984-10-24 | 1986-05-22 | Green Cross Corp:The | フイブロネクチン製剤 |
US5112608A (en) * | 1987-03-13 | 1992-05-12 | Incyte Pharmaceuticals | Use of protease nexin-I to mediate wound healing |
US4837019A (en) * | 1986-08-11 | 1989-06-06 | Charles Of The Ritz Group Ltd. | Skin treatment composition and method for treating burned skin |
US4929442A (en) * | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US5053388A (en) * | 1987-11-09 | 1991-10-01 | Chiron Ophthalmics, Inc. | Wound healing composition and method |
JP2561113B2 (ja) * | 1988-02-16 | 1996-12-04 | 寳酒造株式会社 | 細胞接着活性ポリペプチド |
US5124155A (en) * | 1988-06-21 | 1992-06-23 | Chiron Ophthalmics, Inc. | Fibronectin wound-healing dressings |
US4973466A (en) * | 1988-06-21 | 1990-11-27 | Chiron Ophthalmics, Inc. | Wound-healing dressings and methods |
JP2561131B2 (ja) * | 1988-06-30 | 1996-12-04 | 寳酒造株式会社 | 細胞接着活性ポリペプチド |
FI86339C (fi) * | 1988-12-09 | 1992-08-10 | Ari Tuomi | Diffusionscell foer undersoekning av salvor och liknande. |
JPH04503951A (ja) * | 1988-12-20 | 1992-07-16 | ラ ホヤ キャンサー リサーチ ファウンデーション | 創傷治癒に活性のあるポリペプチド―ポリマー複合体 |
WO1990008833A1 (en) * | 1989-02-02 | 1990-08-09 | Massachusetts Institute Of Technology | Expression of recombinant fibronectin in genetically engineered cells |
ATE92107T1 (de) * | 1989-04-29 | 1993-08-15 | Delta Biotechnology Ltd | N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen. |
GB8909916D0 (en) * | 1989-04-29 | 1989-06-14 | Delta Biotechnology Ltd | Polypeptides |
US5155038A (en) * | 1990-02-22 | 1992-10-13 | W. R. Grace & Co.-Conn. | Use of thrombospondin to promote wound healing |
GB9101191D0 (en) * | 1991-01-18 | 1991-02-27 | Univ London | Wound treatment |
GB9101183D0 (en) * | 1991-01-18 | 1991-02-27 | Univ London | Depot formulations |
-
1995
- 1995-06-07 US US08/488,253 patent/US5641483A/en not_active Expired - Fee Related
-
1996
- 1996-06-06 EP EP05004533A patent/EP1563844A3/en not_active Withdrawn
- 1996-06-06 DE DE69634430T patent/DE69634430T2/de not_active Expired - Fee Related
- 1996-06-06 CA CA002197244A patent/CA2197244A1/en not_active Abandoned
- 1996-06-06 WO PCT/CA1996/000384 patent/WO1996040221A1/en active IP Right Grant
- 1996-06-06 EP EP96917308A patent/EP0784481B1/en not_active Expired - Lifetime
- 1996-06-06 ES ES96917308T patent/ES2236733T3/es not_active Expired - Lifetime
- 1996-06-06 AT AT96917308T patent/ATE290397T1/de not_active IP Right Cessation
- 1996-06-06 PT PT96917308T patent/PT784481E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
DE69634430T2 (de) | 2006-01-05 |
EP0784481A1 (en) | 1997-07-23 |
ATE290397T1 (de) | 2005-03-15 |
EP0784481B1 (en) | 2005-03-09 |
DE69634430D1 (de) | 2005-04-14 |
WO1996040221A1 (en) | 1996-12-19 |
US5641483A (en) | 1997-06-24 |
ES2236733T3 (es) | 2005-07-16 |
EP1563844A3 (en) | 2007-03-14 |
CA2197244A1 (en) | 1996-12-19 |
EP1563844A2 (en) | 2005-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT784481E (pt) | Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano | |
PT859596E (pt) | Formulacoes em gel contendo factores de crescimento | |
BR9702541A (pt) | Composição cosmética e/ou dermatológica utilização da composição e processo para tratamento não-terapêutico cosmético | |
DE59209658D1 (de) | Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung | |
FR2782269B1 (fr) | Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation | |
EP0801946A3 (de) | Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen | |
ATE209032T1 (de) | Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität | |
BR0001210A (pt) | Composição cosmética, produto para tez ou lábios, bastão para tez ou lábios, pó cosmético, processo de tratamento não terapêutico da pele e/ou das mucosas e utilização da associação de pelo menos um composto siliconado e de pelo menos um éster de ácido graxo ou de álcool graxo | |
ES2063250T3 (es) | Uso de la trombospondina para facilitar la curacion de las heridas. | |
ES2113222T3 (es) | Utilizacion de derivados de acido benzoico para estimular el proceso de renovacion epidermica y tratar la piel. | |
DK0951294T3 (da) | Sårhelende formuleringer indeholdende humanplasmafibronectin | |
GB2319729A (en) | A film for topical use in the treatment of wounds | |
BR9809351A (pt) | Tecido de bainha dérmica na cura de lesões | |
EP0801945A3 (de) | Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen | |
BG101126A (en) | The use of muramylpeptide compounds | |
ES2187836T3 (es) | Utilizacion de un extracto de terminalia catappa. | |
WO1996001100A3 (de) | Hydrogel für die applikation von therapeutischen und/oder kosmetischen wirkstoffen an die haut | |
BR9508896A (pt) | COmposição perfumada para o tratamento tópico da pele | |
BR9504089A (pt) | Agente para o tratamento ou cuidado de pele irritada ou inflamada e aplicação | |
BR0109896A (pt) | Composição tópica em gel, curativo de feridas, seu método e uso | |
WO1998030212A3 (de) | Verwendung von aminothiazolen zur verbesserung der wundheilung | |
ATE120959T1 (de) | Wasserlösliche vitamin a-zubereitungen und deren verwendung bei der hautbehandlung. | |
IL122359A0 (en) | Stable gel formulation for topical treatment of skin conditions | |
IT9048186A0 (it) | Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti | |
AU6664598A (en) | Use of curcumin in treatment of psoriasis, inflammation, skin wounds, burns, andeczemas |